Adenosine A1 receptors in the central nervous system: Their functions in health and disease, and possible elucidation by PET imaging

Current Medicinal Chemistry

Volumn 18, Issue 31, 2011, Pages 4820-4835

  Paul, S ^a   Elsinga, P H ^a,b   Ishiwata, K ^c   Dierckx, R A J O ^a,b   Van Waarde, A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b GHENT UNIVERSITY   (Belgium)

^c TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

Adenosine; Alcohol Abuse; Alzheimer Disease; Brain; Drug Development; Epilepsy; Inflammation; Multiple Sclerosis; Pain; Parkinson's Disease; Positron Emission Tomography; Receptor Imaging; Sleep; Stroke

Indexed keywords

2 (1 METHYL 4 PIPERIDINYL) 6 (2 PHENYLPYRAZOLO[1,5 A] PYRIDIN 3 YL) 3(2H) PYRIDAZINONE C 11; 2 CHLOROADENOSINE; 2 ETHYL 8 DICYCLOPROPYL METHYL 3 PROPYLXANTHINE C 11; 5 O (METHYL SELENO) N 6 CYCLOPENTYLADENOSINE SE 75; 5' N (2 FLUOROETHYL) CARBOXAMIDOADENOSINE F 18; 8 CYCLOPENTYL 3 (3 IODOPROP 2 EN 1 YL) 1 PROPYLXANTHINE C 11; 8 DICYCLOPROPYLMETHYL 1 METHYL 3 PROPYLXANTHINE C 11; 8 DICYCLOPROPYLMETHYL 3 PROPYLXANTHINE C 11; ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A1 RECEPTOR ANTAGONIST; ALCOHOL; PAEONIFLORIN; RADIOPHARMACEUTICAL AGENT; THEOPHYLLINE; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT;

ALZHEIMER DISEASE; ARTICLE; BRAIN; BRAIN DAMAGE; BRAIN DEPTH STIMULATION; BRAIN ISCHEMIA; BRAIN METABOLISM; CENTRAL NERVOUS SYSTEM; CREUTZFELDT JAKOB DISEASE; DEGENERATIVE DISEASE; DRUG DISTRIBUTION; DRUG RECEPTOR BINDING; EPILEPSY; HUMAN; LEARNING; MEMORY; MULTIPLE SCLEROSIS; NEUROIMAGING; NONHUMAN; PARKINSON DISEASE; PICK PRESENILE DEMENTIA; POSITRON EMISSION TOMOGRAPHY; PROTEIN EXPRESSION; SCHIZOPHRENIA; SEIZURE; SINGLE NUCLEOTIDE POLYMORPHISM; SLEEP WAKING CYCLE; TRAUMATIC BRAIN INJURY; CENTRAL NERVOUS SYSTEM DISEASE; CHEMISTRY; METABOLISM; PATHOLOGY; REVIEW;

ADENOSINE A1 RECEPTOR AGONISTS; ADENOSINE A1 RECEPTOR ANTAGONISTS; CENTRAL NERVOUS SYSTEM DISEASES; HUMANS; POSITRON-EMISSION TOMOGRAPHY; RECEPTOR, ADENOSINE A1;

EID: 80054872347     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986711797535335     Document Type: Article

References (279)

1. Marchi, M.; Raiteri, L.; Risso, F.; Vallarino, A.; Bonfanti, A.; Monopoli, A.; Ongini, E.; Raiteri, M. Effects of adenosine A1 and A2A receptor activation on the evoked release of glutamate from rat cerebrocortical synaptosomes. Br. J. Pharmacol., 2002, 136, 434-440 (Pubitemid 34620524)
2. Quarta, D.; Ferre, S.; Solinas, M.; You, Z.B.; Hockemeyer, J.; Popoli, P.; Goldberg, S.R. Opposite modulatory roles for adenosine A1 and A2A receptors on glutamate and dopamine release in the shell of the nucleus accumbens. Effects of chronic caffeine exposure. J. Neurochem., 2004, 88, 1151-1158 (Pubitemid 38280682)
3. Ciruela, F.; Casado, V.; Rodrigues, R.J.; Lujan, R.; Burgueno, J.; Canals, M.; Borycz, J.; Rebola, N.; Goldberg, S.R.; Mallol, J.; Cortes, A.; Canela, E.I.; Lopez-Gimenez, J.F.; Milligan, G.; Lluis, C.; Cunha, R.A.; Ferre, S.; Franco, R. Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers. J. Neurosci., 2006, 26, 2080-2087
4. Floran, B.; Barajas, C.; Floran, L.; Erlij, D.; Aceves, J. Adenosine A1 receptors control dopamine D1-dependent [(3)H]GABA release in slices of substantia nigra pars reticulata and motor behavior in the rat. Neuroscience, 2002, 115, 743-751 (Pubitemid 35336017)
5. Jeong, H.J.; Jang, I.S.; Nabekura, J.; Akaike, N. Adenosine A1 receptormediated presynaptic inhibition of GABAergic transmission in immature rat hippocampal CA1 neurons. J. Neurophysiol., 2003, 89, 1214-1222 (Pubitemid 36323969)
6. Yum, D.S.; Cho, J.H.; Choi, I.S.; Nakamura, M.; Lee, J.J.; Lee, M.G.; Choi, B.J.; Choi, J.K.; Jang, I.S. Adenosine A(1) receptors inhibit GABAergic transmission in rat tuberomammillary nucleus neurons. J. Neurochem., 2008, 106, 361-371 (Pubitemid 351840222)
7. Tanase, D.; Baghdoyan, H.A.; Lydic, R. Dialysis delivery of an adenosine A1 receptor agonist to the pontine reticular formation decreases acetylcholine release and increases anesthesia recovery time. Anesthesiology, 2003, 98, 912-920 (Pubitemid 36373226)
8. Arrigoni, E.; Chamberlin, N.L.; Saper, C.B.; McCarley, R.W. Adenosine inhibits basal forebrain cholinergic and noncholinergic neurons in vitro. Neuroscience, 2006, 140, 403-413
9. Van Dort, C.J.; Baghdoyan, H.A.; Lydic, R. Adenosine A(1) and A(2A) receptors in mouse prefrontal cortex modulate acetylcholine release and behavioral arousal. J. Neurosci., 2009, 29, 871-881
10. Ballarin, M.; Reiriz, J.; Ambrosio, S.; Mahy, N. Effect of locally infused 2- chloroadenosine, an A1 receptor agonist, on spontaneous and evoked dopamine release in rat neostriatum. Neurosci. Lett., 1995, 185, 29-32
11. Jin, S.; Fredholm, B.B. Adenosine A1 receptors mediate hypoxia-induced inhibition of electrically evoked transmitter release from rat striatal slices. Eur. J. Pharmacol., 1997, 329, 107-113 (Pubitemid 27270521)
12. Borycz, J.; Pereira, M.F.; Melani, A.; Rodrigues, R.J.; Kofalvi, A.; Panlilio, L.; Pedata, F.; Goldberg, S.R.; Cunha, R.A.; Ferre, S. Differential glutamatedependent and glutamate-independent adenosine A1 receptor-mediated modulation of dopamine release in different striatal compartments. J. Neurochem., 2007, 101, 355-363 (Pubitemid 46525280)
13. Costenla, A.R.; de Mendonca, A.; Ribeiro, J.A. Adenosine modulates synaptic plasticity in hippocampal slices from aged rats. Brain Res., 1999, 851, 228-234 (Pubitemid 30038149)
14. de Mendonca, A.; Ribeiro, J.A. Endogenous adenosine modulates long-term potentiation in the hippocampus. Neuroscience, 1994, 62, 385-390 (Pubitemid 24306663)
15. Rex, C.S.; Kramar, E.A.; Colgin, L.L.; Lin, B.; Gall, C.M.; Lynch, G. Longterm potentiation is impaired in middle-aged rats: Regional specificity and reversal by adenosine receptor antagonists. J. Neurosci., 2005, 25, 5956-5966 (Pubitemid 40911426)
16. Zimmermann, H. Biochemistry, localization and functional roles of ectonucleotidases in the nervous system. Prog. Neurobiol., 1996, 49, 589-618 (Pubitemid 26343246)
17. Zimmermann, H. Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedebergs Arch. Pharmacol., 2000, 362, 299-309
18. Dunwiddie, T.V.; Diao, L.; Proctor, W.R. Adenine nucleotides undergo rapid, quantitative conversion to adenosine in the extracellular space in rat hippocampus. J. Neurosci., 1997, 17, 7673-7682 (Pubitemid 27426206)
19. Latini, S.; Pedata, F. Adenosine in the central nervous system: Release mechanisms and extracellular concentrations. J. Neurochem., 2001, 79, 463-484 (Pubitemid 33029920)
20. James, S.; Richardson, P.J. Production of adenosine from extracellular ATP at the striatal cholinergic synapse. J. Neurochem., 1993, 60, 219-227 (Pubitemid 23006721)
21. Nagy, J.I.; Geiger, J.D.; Daddona, P.E. Adenosine uptake sites in rat brain: Identification using [3H]nitrobenzylthioinosine and co-localization with adenosine deaminase. Neurosci. Lett., 1985, 55, 47-53 (Pubitemid 15103505)
22. Patel, B.T.; Tudball, N. Localization of S-adenosylhomocysteine hydrolase and adenosine deaminase immunoreactivities in rat brain. Brain Res., 1986, 370, 250-264 (Pubitemid 16055065)
23. Reddington, M.; Pusch, R. Adenosine metabolism in a rat hippocampal slice preparation: Incorporation into S-adenosylhomocysteine. J. Neurochem., 1983, 40, 285-290 (Pubitemid 13151639)
24. Collis, M.G.; Hourani, S.M. Adenosine receptor subtypes. Trends Pharmacol. Sci., 1993, 14, 360-366 (Pubitemid 23308759)
25. Fredholm, B.B.; Abbracchio, M.P.; Burnstock, G.; Daly, J.W.; Harden, T.K.; Jacobson, K.A.; Leff, P.; Williams, M. Nomenclature and classification of purinoceptors. Pharmacol. Rev., 1994, 46, 143-156 (Pubitemid 24984777)
26. Haas, H.L.; Selbach, O. Functions of neuronal adenosine receptors. Naunyn Schmiedebergs Arch. Pharmacol., 2000, 362, 375-381
27. Fredholm, B.B.; Ijzerman, A.P.; Jacobson, K.A.; Klotz, K.N.; Linden, J. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev., 2001, 53, 527-552 (Pubitemid 33136237)
28. Fredholm, B.B.; Arslan, G.; Halldner, L.; Kull, B.; Schulte, G.; Wasserman, W. Structure and function of adenosine receptors and their genes. Naunyn Schmiedebergs Arch. Pharmacol., 2000, 362, 364-374
29. Mahan, L.C.; McVittie, L.D.; Smyk-Randall, E.M.; Nakata, H.; Monsma, F.J., Jr.; Gerfen, C.R.; Sibley, D.R. Cloning and expression of an A1 adenosine receptor from rat brain. Mol. Pharmacol., 1991, 40, 1-7
30. Daly, J.W.; Padgett, W.L. Agonist activity of 2- and 5'-substituted adenosine analogs and their N6-cycloalkyl derivatives at A1- and A2-adenosine receptors coupled to adenylate cyclase. Biochem. Pharmacol., 1992, 43, 1089-1093
31. Dixon, A.K.; Gubitz, A.K.; Sirinathsinghji, D.J.; Richardson, P.J.; Freeman, T.C. Tissue distribution of adenosine receptor mRNAs in the rat. Br. J. Pharmacol., 1996, 118, 1461-1468 (Pubitemid 26248800)
32. Fastbom, J.; Pazos, A.; Probst, A.; Palacios, J.M. Adenosine A1 receptors in the human brain: A quantitative autoradiographic study. Neuroscience, 1987, 22, 827-839
33. Fastbom, J.; Pazos, A.; Palacios, J.M. The distribution of adenosine A1 receptors and 5'-nucleotidase in the brain of some commonly used experimental animals. Neuroscience, 1987, 22, 813-826
34. Rivkees, S.A.; Price, S.L.; Zhou, F.C. Immunohistochemical detection of A1 adenosine receptors in rat brain with emphasis on localization in the hippocampal formation, cerebral cortex, cerebellum, and basal ganglia. Brain Res., 1995, 677, 193-203
35. Schindler, M.; Harris, C.A.; Hayes, B.; Papotti, M.; Humphrey, P.P. Immunohistochemical localization of adenosine A1 receptors in human brain regions. Neurosci. Lett., 2001, 297, 211-215 (Pubitemid 32011310)
36. Svenningsson, P.; Hall, H.; Sedvall, G.; Fredholm, B.B. Distribution of adenosine receptors in the postmortem human brain: A n extended autoradiographic study. Synapse, 1997, 27, 322-335 (Pubitemid 27479470)
37. Ochiishi, T.; Chen, L.; Yukawa, A.; Saitoh, Y.; Sekino, Y.; Arai, T.; Nakata, H.; Miyamoto, H. Cellular localization of adenosine A1 receptors in rat forebrain: Immunohistochemical analysis using adenosine A1 receptorspecific monoclonal antibody. J. Comp Neurol., 1999, 411, 301-316 (Pubitemid 29343401)
38. van Calker, D.; Muller, M.; Hamprecht, B. Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J. Neurochem., 1979, 33, 999-1005 (Pubitemid 10188731)
39. Linden, J. Molecular approach to adenosine receptors: Receptor-mediated mechanisms of tissue protection. Annu. Rev. Pharmacol. Toxicol., 2001, 41, 775-787 (Pubitemid 32385906)
40. Santicioli, P.; Del Bianco, E.; Tramontana, M.; Maggi, C.A. Adenosine inhibits action potential-dependent release of calcitonin gene-related peptideand substance P-like immunoreactivities from primary afferents in rat spinal cord. Neurosci. Lett., 1992, 144, 211-214
41. Salter, M.W.; De Koninck, Y.; Henry, J.L. Physiological roles for adenosine and ATP in synaptic transmission in the spinal dorsal horn. Prog. Neurobiol., 1993, 41, 125-156 (Pubitemid 23152303)
42. Li, J.; Perl, E.R. Adenosine inhibition of synaptic transmission in the substantia gelatinosa. J. Neurophysiol., 1994, 72, 1611-1621 (Pubitemid 24325090)
43. Ishiwata, K.; Kimura, Y.; de Vries, E.F.; Elsinga, P.H. PET tracers for mapping adenosine receptors as probes for diagnosis of CNS disorders. CNS Agents Med. Chem., 2007, 7, 57-77 (Pubitemid 46440372)
44. Bauer, A.; Ishiwata, K. Adenosine receptor ligands and PET imaging of the CNS. Handb. Exp. Pharmacol., 2009, 617-642
45. Herzog, H.; Elmenhorst, D.; Winz, O.; Bauer, A. Biodistribution and radiation dosimetry of the A1 adenosine receptor ligand 18F-CPFPX determined from human whole-body PET. Eur. J. Nucl. Med. Mol. Imaging, 2008, 35, 1499-1506
46. Matsuya, T.; Takamatsu, H.; Murakami, Y.; Noda, A.; Ichise, R.; Awaga, Y.; Nishimura, S. Synthesis and evaluation of [11C]FR194921 as a nonxanthinetype PET tracer for adenosine A1 receptors in the brain. Nucl. Med. Biol., 2005, 32, 837-844 (Pubitemid 41505317)
47. Basheer, R.; Strecker, R.E.; Thakkar, M.M.; McCarley, R.W. Adenosine and sleep-wake regulation. Prog. Neurobiol., 2004, 73, 379-396 (Pubitemid 39094087)
48. Porkka-Heiskanen, T.; Strecker, R.E.; Thakkar, M.; Bjorkum, A.A.; Greene, R.W.; McCarley, R.W. Adenosine: A mediator of the sleep-inducing effects of prolonged wakefulness. Science, 1997, 276, 1265-1268
49. Elmenhorst, D.; Meyer, P.T.; Winz, O.H.; Matusch, A.; Ermert, J.; Coenen, H.H.; Basheer, R.; Haas, H.L.; Zilles, K.; Bauer, A. Sleep deprivation increases A1 adenosine receptor binding in the human brain: A positron emission tomography study. J. Neurosci., 2007, 27, 2410-2415 (Pubitemid 46340969)
50. Basheer, R.; Halldner, L.; Alanko, L.; McCarley, R.W.; Fredholm, B.B.; Porkka-Heiskanen, T. Opposite changes in adenosine A1 and A2A receptor mRNA in the rat following sleep deprivation. Neuroreport, 2001, 12, 1577-1580 (Pubitemid 32521466)
51. Basheer, R.; Bauer, A.; Elmenhorst, D.; Ramesh, V.; McCarley, R.W. Sleep deprivation upregulates A1 adenosine receptors in the rat basal forebrain. Neuroreport, 2007, 18, 1895-1899 (Pubitemid 350135408)
52. Elmenhorst, D.; Basheer, R.; McCarley, R.W.; Bauer, A. Sleep deprivation increases A(1) adenosine receptor density in the rat brain. Brain Res., 2009, 1258, 53-58
53. Yanik, G.; Radulovacki, M. REM sleep deprivation up-regulates adenosine A1 receptors. Brain Res., 1987, 402, 362-364 (Pubitemid 17005308)
54. Bjorness, T.E.; Kelly, C.L.; Gao, T.; Poffenberger, V.; Greene, R.W. Control and function of the homeostatic sleep response by adenosine A1 receptors. J. Neurosci., 2009, 29, 1267-1276
55. Huber, R.; Ghilardi, M.F.; Massimini, M.; Tononi, G. Local sleep and learning. Nature, 2004, 430, 78-81 (Pubitemid 38915227)
56. Benington, J.H.; Kodali, S.K.; Heller, H.C. Stimulation of A1 adenosine receptors mimics the electroencephalographic effects of sleep deprivation. Brain Res., 1995, 692, 79-85
57. Strecker, R.E.; Morairty, S.; Thakkar, M.M.; Porkka-Heiskanen, T.; Basheer, R.; Dauphin, L.J.; Rainnie, D.G.; Portas, C.M.; Greene, R.W.; McCarley, R.W. Adenosinergic modulation of basal forebrain and preoptic/anterior hypothalamic neuronal activity in the control of behavioral state. Behav. Brain Res., 2000, 115, 183-204
58. Christie, M.A.; Bolortuya, Y.; Chen, L.C.; McKenna, J.T.; McCarley, R.W.; Strecker, R.E. Microdialysis elevation of adenosine in the basal forebrain produces vigilance impairments in the rat psychomotor vigilance task. Sleep, 2008, 31, 1393-1398
59. Thakkar, M.M.; Winston, S.; McCarley, R.W. A1 receptor and adenosinergic homeostatic regulation of sleep-wakefulness: E ffects of antisense to the A1 receptor in the cholinergic basal forebrain. J. Neurosci., 2003, 23, 4278-4287 (Pubitemid 36958448)
60. Dunwiddie, T.V.; Masino, S.A. The role and regulation of adenosine in the central nervous system. Annu. Rev. Neurosci., 2001, 24, 31-55 (Pubitemid 32695222)
61. Portas, C.M.; Thakkar, M.; Rainnie, D.G.; Greene, R.W.; McCarley, R.W. Role of adenosine in behavioral state modulation: A microdialysis study in the freely moving cat. Neuroscience, 1997, 79, 225-235 (Pubitemid 27245013)
62. Ticho, S.R.; Radulovacki, M. Role of adenosine in sleep and temperature regulation in the preoptic area of rats. Pharmacol. Biochem. Behav., 1991, 40, 33-40
63. Lin, A.S.; Uhde, T.W.; Slate, S.O.; McCann, U.D. Effects of intravenous caffeine administered to healthy males during sleep. Depress. Anxiety., 1997, 5, 21-28 (Pubitemid 28106009)
64. Basheer, R.; Rainnie, D.G.; Porkka-Heiskanen, T.; Ramesh, V.; McCarley, R.W. Adenosine, prolonged wakefulness, and A1-activated NF-kappaB DNA binding in the basal forebrain of the rat. Neuroscience, 2001, 104, 731-739 (Pubitemid 32607425)
65. Ramesh, V.; Thatte, H.S.; McCarley, R.W.; Basheer, R. Adenosine and sleep deprivation promote NF-kappaB nuclear translocation in cholinergic basal forebrain. J. Neurochem., 2007, 100, 1351-1363
66. Thakkar, M.M.; Winston, S.; McCarley, R.W. Orexin neurons of the hypothalamus express adenosine A1 receptors. Brain Res., 2002, 944, 190-194 (Pubitemid 34775021)
67. Liu, Z.W.; Gao, X.B. Adenosine inhibits activity of hypocretin/orexin neurons by the A1 receptor in the lateral hypothalamus: A possible sleeppromoting effect. J. Neurophysiol., 2007, 97, 837-848
68. Alam, M.N.; Kumar, S.; Rai, S.; Methippara, M.; Szymusiak, R.; McGinty, D. Role of adenosine A(1) receptor in the perifornical-lateral hypothalamic area in sleep-wake regulation in rats. Brain Res., 2009, 1304, 96-104
69. Thakkar, M.M.; Engemann, S.C.; Walsh, K.M.; Sahota, P.K. Adenosine and the homeostatic control of sleep: E ffects of A1 receptor blockade in the perifornical lateral hypothalamus on sleep-wakefulness. Neuroscience, 2008, 153, 875-880
70. Oishi, Y.; Huang, Z.L.; Fredholm, B.B.; Urade, Y.; Hayaishi, O. Adenosine in the tuberomammillary nucleus inhibits the histaminergic system via A1 receptors and promotes non-rapid eye movement sleep. Proc. Natl. Acad. Sci. U. S. A, 2008, 105, 19992-19997
71. Marks, G.A.; Birabil, C.G.; Speciale, S.G. Adenosine A1 receptors mediate inhibition of cAMP formation in vitro in the pontine, REM sleep induction zone. Brain Res., 2005, 1061, 124-127 (Pubitemid 41587921)
72. Methippara, M.M.; Kumar, S.; Alam, M.N.; Szymusiak, R.; McGinty, D. Effects on sleep of microdialysis of adenosine A1 and A2a receptor analogs into the lateral preoptic area of rats. Am. J. Physiol Regul. Integr. Comp Physiol, 2005, 289, R1715-R1723 (Pubitemid 41643216)
73. Arai, A.; Kessler, M.; Lynch, G. The effects of adenosine on the development of long-term potentiation. Neurosci. Lett., 1990, 119, 41-44 (Pubitemid 20349722)
74. Normile, H.J.; Gaston, S.; Johnson, G.; Barraco, R.A. Activation of adenosine A1 receptors in the nucleus accumbens impairs inhibitory avoidance memory. Behav. Neural Biol., 1994, 62, 163-166
75. Normile, H.J.; Barraco, R.A. N6-cyclopentyladenosine impairs passive avoidance retention by selective action at A1 receptors. Brain Res. Bull., 1991, 27, 101-104
76. Ohno, M.; Watanabe, S. Working memory failure by stimulation of hippocampal adenosine A1 receptors in rats. Neuroreport, 1996, 7, 3013-3016 (Pubitemid 26426380)
77. Corodimas, K.P.; Tomita, H. Adenosine A1 receptor activation selectively impairs the acquisition of contextual fear conditioning in rats. Behav. Neurosci., 2001, 115, 1283-1290 (Pubitemid 33139135)
78. Prediger, R.D.; Takahashi, R.N. Modulation of short-term social memory in rats by adenosine A1 and A(2A) receptors. Neurosci. Lett., 2005, 376, 160-165 (Pubitemid 40255302)
79. Pereira, G.S.; Mello e Souza; Vinade, E.R.; Choi, H.; Rodrigues, C.; Battastini, A.M.; Izquierdo, I.; Sarkis, J.J.; Bonan, C.D. Blockade of adenosine A1 receptors in the posterior cingulate cortex facilitates memory in rats. Eur. J. Pharmacol., 2002, 437, 151-154
80. Von Lubitz, D.K.; Paul, I.A.; Bartus, R.T.; Jacobson, K.A. Effects of chronic administration of adenosine A1 receptor agonist and antagonist on spatial learning and memory. Eur. J. Pharmacol., 1993, 249, 271-280 (Pubitemid 23334100)
81. Gimenez-Llort, L.; Fernandez-Teruel, A.; Escorihuela, R.M.; Fredholm, B.B.; Tobena, A.; Pekny, M.; Johansson, B. Mice lacking the adenosine A1 receptor are anxious and aggressive, but are normal learners with reduced muscle strength and survival rate. Eur. J. Neurosci., 2002, 16, 547-550 (Pubitemid 35471874)
82. Lang, U.E.; Lang, F.; Richter, K.; Vallon, V.; Lipp, H.P.; Schnermann, J.; Wolfer, D.P. Emotional instability but intact spatial cognition in adenosine receptor 1 knock out mice. Behav. Brain Res., 2003, 145, 179-188 (Pubitemid 37188643)
83. Gimenez-Llort, L.; Masino, S.A.; Diao, L.; Fernandez-Teruel, A.; Tobena, A.; Halldner, L.; Fredholm, B.B. Mice lacking the adenosine A1 receptor have normal spatial learning and plasticity in the CA1 region of the hippocampus, but they habituate more slowly. Synapse, 2005, 57, 8-16 (Pubitemid 40756330)
84. Nagy, L.E. Ethanol metabolism and inhibition of nucleoside uptake lead to increased extracellular adenosine in hepatocytes. Am. J. Physiol, 1992, 262, C1175-C1180
85. Nagy, L.E.; Diamond, I.; Casso, D.J.; Franklin, C.; Gordon, A.S. Ethanol increases extracellular adenosine by inhibiting adenosine uptake via the nucleoside transporter. J. Biol. Chem., 1990, 265, 1946-1951
86. Krauss, S.W.; Ghirnikar, R.B.; Diamond, I.; Gordon, A.S. Inhibition of adenosine uptake by ethanol is specific for one class of nucleoside transporters. Mol. Pharmacol., 1993, 44, 1021-1026 (Pubitemid 23344970)
87. Choi, D.S.; Cascini, M.G.; Mailliard, W.; Young, H.; Paredes, P.; McMahon, T.; Diamond, I.; Bonci, A.; Messing, R.O. The type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference. Nat. Neurosci., 2004, 7, 855-861 (Pubitemid 38989509)
88. Allen-Gipson, D.S.; Jarrell, J.C.; Bailey, K.L.; Robinson, J.E.; Kharbanda, K.K.; Sisson, J.H.; Wyatt, T.A. Ethanol blocks adenosine uptake via inhibiting the nucleoside transport system in bronchial epithelial cells. Alcohol Clin. Exp. Res., 2009, 33, 791-798
89. Clark, M.; Dar, M.S. Effect of acute ethanol on uptake of [3H]adenosine by rat cerebellar synaptosomes. Alcohol Clin. Exp. Res., 1989, 13, 371-377 (Pubitemid 19185714)
90. Clark, M.; Dar, M.S. Effect of acute ethanol on release of endogenous adenosine from rat cerebellar synaptosomes. J. Neurochem., 1989, 52, 1859-1865 (Pubitemid 19140774)
91. Clark, M.; Dar, M.S. The effects of various methods of sacrifice and of ethanol on adenosine levels in selected areas of rat brain. J. Neurosci. Methods, 1988, 25, 243-249
92. Phillis, J.W.; O'Regan, M.H.; Perkins, L.M. Actions of ethanol and acetate on rat cortical neurons: E thanol/adenosine interactions. Alcohol, 1992, 9, 541-546
93. Kiselevski, Y.; Oganesian, N.; Zimatkin, S.; Szutowicz, A.; Angielski, S.; Niezabitowski, P.; Uracz, W.; Gryglewski, R.J. Acetate metabolism in brain mechanisms of adaptation to ethanol. Med. Sci. Monit., 2003, 9, BR178- BR182 (Pubitemid 36713432)
94. Sharma, R.; Engemann, S.C.; Sahota, P.; Thakkar, M.M. Effects of ethanol on extracellular levels of adenosine in the basal forebrain: A n in vivo microdialysis study in freely behaving rats. Alcohol Clin. Exp. Res., 2010, 34, 813-818
95. Dar, M.S.; Mustafa, S.J.; Wooles, W.R. Possible role of adenosine in the CNS effects of ethanol. Life Sci., 1983, 33, 1363-1374 (Pubitemid 13007374)
96. Clark, M.; Dar, M.S. Mediation of acute ethanol-induced motor disturbances by cerebellar adenosine in rats. Pharmacol. Biochem. Behav., 1988, 30, 155-161 (Pubitemid 19268805)
97. Barwick, V.S.; Dar, M.S. Adenosinergic modulation of ethanol-induced motor incoordination in the rat motor cortex. Prog. Neuropsychopharmacol. Biol. Psychiatry, 1998, 22, 587-607 (Pubitemid 28281225)
98. Meng, Z.H.; Dar, M.S. Possible role of striatal adenosine in the modulation of acute ethanol-induced motor incoordination in rats. Alcohol Clin. Exp. Res., 1995, 19, 892-901
99. Dar, M.S. Modulation of ethanol-induced motor incoordination by mouse striatal A(1) adenosinergic receptor. Brain Res. Bull., 2001, 55, 513-520 (Pubitemid 32785638)
100. Connole, L.; Harkin, A.; Maginn, M. Adenosine A1 receptor blockade mimics caffeine's attenuation of ethanol-induced motor incoordination. Basic Clin. Pharmacol. Toxicol., 2004, 95, 299-304 (Pubitemid 39657647)
101. Dar, M.S. Mouse cerebellar adenosinergic modulation of ethanol-induced motor incoordination: Possible involvement of cAMP. Brain Res., 1997, 749, 263-274 (Pubitemid 27104207)
102. Dar, M.S. Brain adenosinergic modulation of acute ethanol-induced motor impairment. Alcohol Alcohol Suppl, 1993, 2, 425-429
103. Dar, M.S.; Mustafa, S.J. Acute ethanol/cannabinoid-induced ataxia and its antagonism by oral/systemic/intracerebellar A1 adenosine receptor antisense in mice. Brain Res., 2002, 957, 53-60 (Pubitemid 35346573)
104. Phan, T.A.; Gray, A.M.; Nyce, J.W. Intrastriatal adenosine A1 receptor antisense oligodeoxynucleotide blocks ethanol-induced motor incoordination. Eur. J. Pharmacol., 1997, 323, R5-R7
105. Reynolds, J.D.; Brien, J.F. The role of adenosine A1 receptor activation in ethanol-induced inhibition of stimulated glutamate release in the hippocampus of the fetal and adult guinea pig. Alcohol, 1995, 12, 151-157
106. Clark, M.; Dar, M.S. Release of endogenous glutamate from rat cerebellar synaptosomes: Interactions with adenosine and ethanol. Life Sci., 1989, 44, 1625-1635 (Pubitemid 19163686)
107. Meng, Z.H.; Anwer, J.; Dar, M.S. The striatal adenosinergic modulation of ethanol-induced motor incoordination in rats: Possible role of chloride flux. Brain Res., 1997, 776, 235-245 (Pubitemid 28018480)
108. Carmichael, F.J.; Israel, Y.; Crawford, M.; Minhas, K.; Saldivia, V.; Sandrin, S.; Campisi, P.; Orrego, H. Central nervous system effects of acetate: C ontribution to the central effects of ethanol. J. Pharmacol. Exp. Ther., 1991, 259, 403-408
109. Carmichael, F.J.; Orrego, H.; Israel, Y. Acetate-induced adenosine mediated effects of ethanol. Alcohol Alcohol Suppl, 1993, 2, 411-418
110. Israel, Y.; Orrego, H.; Carmichael, F.J. Acetate-mediated effects of ethanol. Alcohol Clin. Exp. Res., 1994, 18, 144-148 (Pubitemid 24136771)
111. Campisi, P.; Carmichael, F.J.; Crawford, M.; Orrego, H.; Khanna, J.M. Role of adenosine in the ethanol-induced potentiation of the effects of general anesthetics in rats. Eur. J. Pharmacol., 1997, 325, 165-172 (Pubitemid 27199565)
112. Drake, C.L.; Roehrs, T.; Turner, L.; Scofield, H.M.; Roth, T. Caffeine reversal of ethanol effects on the multiple sleep latency test, memory, and psychomotor performance. Neuropsychopharmacology, 2003, 28, 371-378
113. Thakkar, M.M.; Engemann, S.C.; Sharma, R.; Sahota, P. Role of wakepromoting basal forebrain and adenosinergic mechanisms in sleep-promoting effects of ethanol. Alcohol Clin. Exp. Res., 2010, 34, 997-1005
114. Prediger, R.D.; Batista, L.C.; Takahashi, R.N. Adenosine A1 receptors modulate the anxiolytic-like effect of ethanol in the elevated plus-maze in mice. Eur. J. Pharmacol., 2004, 499, 147-154 (Pubitemid 39201221)
115. Concas, A.; Cuccheddu, T.; Floris, S.; Mascia, M.P.; Biggio, G. 2-Chloro- N6-cyclopentyladenosine (CCPA), an adenosine A1 receptor agonist, suppresses ethanol withdrawal syndrome in rats. Alcohol Alcohol, 1994, 29, 261-264
116. Kaplan, G.B.; Bharmal, N.H.; Leite-Morris, K.A.; Adams, W.R. Role of adenosine A1 and A2A receptors in the alcohol withdrawal syndrome. Alcohol, 1999, 19, 157-162 (Pubitemid 29467513)
117. Gatch, M.B.; Wallis, C.J.; Lal, H. The effects of adenosine ligands R-PIA and CPT on ethanol withdrawal. Alcohol, 1999, 19, 9-14 (Pubitemid 29415266)
118. Prediger, R.D.; da Silva, G.E.; Batista, L.C.; Bittencourt, A.L.; Takahashi, R.N. Activation of adenosine A1 receptors reduces anxiety-like behavior during acute ethanol withdrawal (hangover) in mice. Neuropsychopharmacology, 2006, 31, 2210-2220 (Pubitemid 44413198)
119. Butler, T.R.; Smith, K.J.; Self, R.L.; Braden, B.B.; Prendergast, M.A. Sex differences in the neurotoxic effects of adenosine A1 receptor antagonism during ethanol withdrawal: Reversal with an A1 receptor agonist or an NMDA receptor antagonist. Alcohol Clin. Exp. Res., 2008, 32, 1260-1270
120. Butler, T.R.; Smith, K.J.; Berry, J.N.; Sharrett-Field, L.J.; Prendergast, M.A. Sex differences in caffeine neurotoxicity following chronic ethanol exposure and withdrawal. Alcohol Alcohol, 2009, 44, 567-574
121. Clark, M.; Dar, M.S. In vitro autoradiographic evidence for adenosine modulation of ethanol-induced motor disturbances in rats. Alcohol Alcohol Suppl, 1991, 1, 203-206
122. Concas, A.; Mascia, M.P.; Cuccheddu, T.; Floris, S.; Mostallino, M.C.; Perra, C.; Satta, S.; Biggio, G. Chronic ethanol intoxication enhances [3H]CCPA binding and does not reduce A1 adenosine receptor function in rat cerebellum. Pharmacol. Biochem. Behav., 1996, 53, 249-255 (Pubitemid 26060764)
123. Daly, J.W.; Shi, D.; Wong, V.; Nikodijevic, O. Chronic effects of ethanol on central adenosine function of mice. Brain Res., 1994, 650, 153-156 (Pubitemid 24207057)
124. Jarvis, M.F.; Becker, H.C. Single and repeated episodes of ethanol withdrawal increase adenosine A1, but not A2A, receptor density in mouse brain. Brain Res., 1998, 786, 80-88 (Pubitemid 28191716)
125. Sharma, R.; Engemann, S.; Sahota, P.; Thakkar, M.M. Role of adenosine and wake-promoting basal forebrain in insomnia and associated sleep disruptions caused by ethanol dependence. J. Neurochem., 2010, 115, 782-794
126. Paul, S.; Khanapur, S.; Rybczynska, A.A.; Kwizera, C.; Sijbesma, J.W.; Ishiwata, K.; Willemsen, A.T.; Elsinga, P.H.; Dierckx, R.A.; van Waarde A. Small-Animal PET Study of Adenosine A1 Receptors in Rat Brain: Blocking Receptors and Raising Extracellular Adenosine. J Nucl. Med., 2011, 52, 1293-1300
127. Laghi Pasini, F.; Guideri, F.; Picano, E.; Parenti, G.; Petersen, C.; Varga, A.; Di Perri, T. Increase in plasma adenosine during brain ischemia in man: A study during transient ischemic attacks, and stroke. Brain Res. Bull., 2000, 51, 327-330 (Pubitemid 30126024)
128. O'Regan, M.H.; Simpson, R.E.; Perkins, L.M.; Phillis, J.W. Adenosine receptor agonists inhibit the release of gamma-aminobutyric acid (GABA) from the ischemic rat cerebral cortex. Brain Res., 1992, 582, 22-26
129. Simpson, R.E.; O'Regan, M.H.; Perkins, L.M.; Phillis, J.W. Excitatory transmitter amino acid release from the ischemic rat cerebral cortex: E ffects of adenosine receptor agonists and antagonists. J. Neurochem., 1992, 58, 1683-1690
130. Marangos, P.J. Adenosinergic approaches to stroke therapeutics. Med. Hypotheses, 1990, 32, 45-49 (Pubitemid 20152415)
131. Ilie, A.; Ciocan, D.; Zagrean, A.M.; Nita, D.A.; Zagrean, L.; Moldovan, M. Endogenous activation of adenosine A(1) receptors accelerates ischemic suppression of spontaneous electrocortical activity. J. Neurophysiol., 2006, 96, 2809-2814 (Pubitemid 44785929)
132. Ilie, A.; Ciocan, D.; Constantinescu, A.O.; Zagrean, A.M.; Nita, D.A.; Zagrean, L.; Moldovan, M. Endogenous activation of adenosine A1 receptors promotes post-ischemic electrocortical burst suppression. Neuroscience, 2009, 159, 1070-1078
133. Pearson, T.; Damian, K.; Lynas, R.E.; Frenguelli, B.G. Sustained elevation of extracellular adenosine and activation of A1 receptors underlie the postischaemic inhibition of neuronal function in rat hippocampus in vitro. J. Neurochem., 2006, 97, 1357-1368 (Pubitemid 43725575)
134. Pignataro, G.; Simon, R.P.; Boison, D. Transgenic overexpression of adenosine kinase aggravates cell death in ischemia. J. Cereb. Blood Flow Metab, 2007, 27, 1-5 (Pubitemid 46006578)
135. Heurteaux, C.; Lauritzen, I.; Widmann, C.; Lazdunski, M. Essential role of adenosine, adenosine A1 receptors, and ATP-sensitive K+ channels in cerebral ischemic preconditioning. Proc. Natl. Acad. Sci. U. S. A, 1995, 92, 4666-4670
136. Nakamura, M.; Nakakimura, K.; Matsumoto, M.; Sakabe, T. Rapid tolerance to focal cerebral ischemia in rats is attenuated by adenosine A1 receptor antagonist. J. Cereb. Blood Flow Metab, 2002, 22, 161-170 (Pubitemid 34135647)
137. Akaiwa, K.; Akashi, H.; Harada, H.; Sakashita, H.; Hiromatsu, S.; Kano, T.; Aoyagi, S. Moderate cerebral venous congestion induces rapid cerebral protection via adenosine A1 receptor activation. Brain Res., 2006, 1122, 47-55 (Pubitemid 44708114)
138. Liu, Y.; Xiong, L.; Chen, S.; Wang, Q. Isoflurane tolerance against focal cerebral ischemia is attenuated by adenosine A1 receptor antagonists. Can. J. Anaesth., 2006, 53, 194-201
139. Mizumura, T.; Auchampach, J.A.; Linden, J.; Bruns, R.F.; Gross, G.J. PD 81,723, an allosteric enhancer of the A1 adenosine receptor, lowers the threshold for ischemic preconditioning in dogs. Circ. Res., 1996, 79, 415-423 (Pubitemid 26276902)
140. Heron, A.; Lekieffre, D.; Le Peillet, E.; Lasbennes, F.; Seylaz, J.; Plotkine, M.; Boulu, R.G. Effects of an A1 adenosine receptor agonist on the neurochemical, behavioral and histological consequences of ischemia. Brain Res., 1994, 641, 217-224 (Pubitemid 24101289)
141. Tominaga, K.; Shibata, S.; Watanabe, S. A neuroprotective effect of adenosine A1-receptor agonists on ischemia-induced decrease in 2- deoxyglucose uptake in rat hippocampal slices. Neurosci. Lett., 1992, 145, 67-70
142. Von Lubitz, D.K.; Lin, R.C.; Melman, N.; Ji, X.D.; Carter, M.F.; Jacobson, K.A. Chronic administration of selective adenosine A1 receptor agonist or antagonist in cerebral ischemia. Eur. J. Pharmacol., 1994, 256, 161-167 (Pubitemid 24124942)
143. Von Lubitz, D.K.; Beenhakker, M.; Lin, R.C.; Carter, M.F.; Paul, I.A.; Bischofberger, N.; Jacobson, K.A. Reduction of postischemic brain damage and memory deficits following treatment with the selective adenosine A1 receptor agonist. Eur. J. Pharmacol., 1996, 302, 43-48 (Pubitemid 26179928)
144. Sweeney, M.I. Neuroprotective effects of adenosine in cerebral ischemia: Window of opportunity. Neurosci. Biobehav. Rev., 1997, 21, 207-217 (Pubitemid 27102566)
145. Rudolphi, K.A.; Keil, M.; Fastbom, J.; Fredholm, B.B. Ischaemic damage in gerbil hippocampus is reduced following upregulation of adenosine (A1) receptors by caffeine treatment. Neurosci. Lett., 1989, 103, 275-280 (Pubitemid 19214401)
146. Halle, J.N.; Kasper, C.E.; Gidday, J.M.; Koos, B.J. Enhancing adenosine A1 receptor binding reduces hypoxic-ischemic brain injury in newborn rats. Brain Res., 1997, 759, 309-312 (Pubitemid 27286712)
147. Phillis, J.W. The effects of selective A1 and A2a adenosine receptor antagonists on cerebral ischemic injury in the gerbil. Brain Res., 1995, 705, 79-84
148. Jacobson, K.A.; Von Lubitz, D.K.; Daly, J.W.; Fredholm, B.B. Adenosine receptor ligands: D ifferences with acute versus chronic treatment. Trends Pharmacol. Sci., 1996, 17, 108-113 (Pubitemid 26112796)
149. Von Lubitz, D.K.; Lin, R.C.; Bischofberger, N.; Beenhakker, M.; Boyd, M.; Lipartowska, R.; Jacobson, K.A. Protection against ischemic damage by adenosine amine congener, a potent and selective adenosine A1 receptor agonist. Eur. J. Pharmacol., 1999, 369, 313-317 (Pubitemid 29155296)
150. Aden, U.; Lindstrom, K.; Bona, E.; Hagberg, H.; Fredholm, B.B. Changes in adenosine receptors in the neonatal rat brain following hypoxic ischemia. Brain Res. Mol. Brain Res., 1994, 23, 354-358 (Pubitemid 24158090)
151. Araki, T.; Kato, H.; Kogure, K.; Saito, T. Postischemic alteration of muscarinic acetylcholine, adenosine A1 and calcium antagonist binding sites in selectively vulnerable areas: A n autoradiographic study of gerbil brain. J. Neurol. Sci., 1991, 106, 206-212
152. Nagasawa, H.; Araki, T.; Kogure, K. Alteration of adenosine A1 receptor binding in the post-ischaemic rat brain. Neuroreport, 1994, 5, 1453-1456
153. Shen, H.; Zhang, L.; Yuen, D.; Logan, R.; Jung, B.P.; Zhang, G.; Eubanks, J.H. Expression and function of A1 adenosine receptors in the rat hippocampus following transient forebrain ischemia. Neuroscience, 2002, 114, 547-556 (Pubitemid 35247643)
154. Lai, D.M.; Tu, Y.K.; Liu, I.M.; Cheng, J.T. Increase of adenosine A1 receptor gene expression in cerebral ischemia of Wistar rats. Neurosci. Lett., 2005, 387, 59-61
155. Nariai, T.; Shimada, Y.; Ishiwata, K.; Nagaoka, T.; Shimada, J.; Kuroiwa, T.; Ono, K.I.; Hirakawa, K.; Senda, M.; Ohno, K. PET neuroreceptor imaging as predictor of severe cerebral ischemic insult. Acta Neurochir. Suppl, 2003, 86, 45-48
156. Nariai, T.; Shimada, Y.; Ishiwata, K.; Nagaoka, T.; Shimada, J.; Kuroiwa, T.; Ono, K.; Ohno, K.; Hirakawa, K.; Senda, M. PET imaging of adenosine A(1) receptors with (11)C-MPDX as an indicator of severe cerebral ischemic insult. J. Nucl. Med., 2003, 44, 1839-1844 (Pubitemid 39663318)
157. Dunwiddie, T.V. Adenosine and suppression of seizures. Adv. Neurol., 1999, 79, 1001-1010
158. Abdul-Ghani, A.S.; Attwell, P.J.; Bradford, H.F. The protective effect of 2- chloroadenosine against the development of amygdala kindling and on amygdala-kindled seizures. Eur. J. Pharmacol., 1997, 326, 7-14 (Pubitemid 27205039)
159. Barraco, R.A.; Swanson, T.H.; Phillis, J.W.; Berman, R.F. Anticonvulsant effects of adenosine analogues on amygdaloid-kindled seizures in rats. Neurosci. Lett., 1984, 46, 317-322 (Pubitemid 14105555)
160. Bortolotto, Z.A.; Mello, L.E.; Turski, L.; Cavalheiro, E.A. Effects of 2- chloroadenosine on amygdaloid and hippocampal kindled seizures. Arch. Int. Pharmacodyn. Ther., 1985, 277, 313-320 (Pubitemid 16226480)
161. Rezvani, M.E.; Mirnajafi-Zadeh, J.; Fathollahi, Y.; Palizvan, M.R. Anticonvulsant effect of A1 but not A2A adenosine receptors of piriform cortex in amygdala-kindled rats. Can. J. Physiol Pharmacol., 2007, 85, 606-612 (Pubitemid 47518029)
162. Rosen, J.B.; Berman, R.F. Differential effects of adenosine analogs on amygdala, hippocampus, and caudate nucleus kindled seizures. Epilepsia, 1987, 28, 658-666 (Pubitemid 18021804)
163. Heidarianpour, A.; Sadeghian, E.; Mirnajafi-Zadeh, J.; Fathollahi, Y.; Mohammad-Zadeh, M. Anticonvulsant effects of N6-cyclohexyladenosine microinjected into the CA1 region of the hippocampus on entorhinal cortexkindled seizures in rats. Epileptic. Disord., 2006, 8, 259-266 (Pubitemid 44912969)
164. Hosseinmardi, N.; Mirnajafi-Zadeh, J.; Fathollahi, Y.; Shahabi, P. The role of adenosine A1 and A2A receptors of entorhinal cortex on piriform cortex kindled seizures in rats. Pharmacol. Res., 2007, 56, 110-117 (Pubitemid 47302793)
165. Namvar, S.; Mirnajafi-Zadeh, J.; Fathollahi, Y.; Zeraati, M. The role of piriform cortex adenosine A1 receptors on hippocampal kindling. Can. J. Neurol. Sci., 2008, 35, 226-231 (Pubitemid 351831062)
166. Gouder, N.; Fritschy, J.M.; Boison, D. Seizure suppression by adenosine A1 receptor activation in a mouse model of pharmacoresistant epilepsy. Epilepsia, 2003, 44, 877-885 (Pubitemid 36842176)
167. Vianna, E.P.; Ferreira, A.T.; Dona, F.; Cavalheiro, E.A.; Silva Fernandes, M.J. Modulation of seizures and synaptic plasticity by adenosinergic receptors in an experimental model of temporal lobe epilepsy induced by pilocarpine in rats. Epilepsia, 2005, 46 Suppl 5, 166-173 (Pubitemid 40962141)
168. Zgodzinski, W.; Rubaj, A.; Kleinrok, Z.; Sieklucka-Dziuba, M. Effect of adenosine A1 and A2 receptor stimulation on hypoxia-induced convulsions in adult mice. Pol. J. Pharmacol., 2001, 53, 83-92 (Pubitemid 32288344)
169. Shahabi, P.; Mirnajafi-Zadeh, J.; Fathollahi, Y.; Hoseinmardi, N.; Rezvani, M.E.; Eslami-far, A. Amygdala adenosine A1 receptors have no anticonvulsant effect on piriform cortex-kindled seizures in rat. Can. J. Physiol Pharmacol., 2006, 84, 913-921 (Pubitemid 46132216)
170. Wiesner, J.B.; Ugarkar, B.G.; Castellino, A.J.; Barankiewicz, J.; Dumas, D.P.; Gruber, H.E.; Foster, A.C.; Erion, M.D. Adenosine kinase inhibitors as a novel approach to anticonvulsant therapy. J. Pharmacol. Exp. Ther., 1999, 289, 1669-1677 (Pubitemid 29246705)
171. Gouder, N.; Scheurer, L.; Fritschy, J.M.; Boison, D. Overexpression of adenosine kinase in epileptic hippocampus contributes to epileptogenesis. J. Neurosci., 2004, 24, 692-701 (Pubitemid 38166495)
172. Li, T.; Quan Lan, J.; Fredholm, B.B.; Simon, R.P.; Boison, D. Adenosine dysfunction in astrogliosis: C ause for seizure generation? Neuron Glia Biol., 2007, 3, 353-366 (Pubitemid 351944155)
173. Guttinger, M.; Padrun, V.; Pralong, W.F.; Boison, D. Seizure suppression and lack of adenosine A1 receptor desensitization after focal long-term delivery of adenosine by encapsulated myoblasts. Exp. Neurol., 2005, 193, 53-64 (Pubitemid 40463267)
174. Eldridge, F.L.; Paydarfar, D.; Scott, S.C.; Dowell, R.T. Role of endogenous adenosine in recurrent generalized seizures. Exp. Neurol., 1989, 103, 179-185 (Pubitemid 19047247)
175. Dragunow, M.; Robertson, H.A. 8-Cyclopentyl 1,3-dimethylxanthine prolongs epileptic seizures in rats. Brain Res., 1987, 417, 377-379 (Pubitemid 17158869)
176. Fukuda, M.; Suzuki, Y.; Hino, H.; Kuzume, K.; Morimoto, T.; Ishii, E. Adenosine A1 receptor blockage mediates theophylline-associated seizures. Epilepsia, 2010, 51, 483-487
177. Mohammad-Zadeh, M.; Mirnajafi-Zadeh, J.; Fathollahi, Y.; Javan, M.; Jahanshahi, A.; Noorbakhsh, S.M.; Motamedi, F. The role of adenosine A(1) receptors in mediating the inhibitory effects of low frequency stimulation of perforant path on kindling acquisition in rats. Neuroscience, 2009, 158, 1632-1643
178. Daval, J.; Werck, M. Autoradiographic changes in brain adenosine A1 receptors and their coupling to G proteins following seizures in the developing rat. Brain Res. Dev. Brain Res., 1991, 59, 237-247
179. Tchekalarova, J.; Sotiriou, E.; Georgiev, V.; Kostopoulos, G.; Angelatou, F. Up-regulation of adenosine A1 receptor binding in pentylenetetrazol kindling in mice: E ffects of angiotensin IV. Brain Res., 2005, 1032, 94-103 (Pubitemid 40170313)
180. Pagonopoulou, O.; Angelatou, F.; Kostopoulos, G. Effect of pentylentetrazol-induced seizures on A1 adenosine receptor regional density in the mouse brain: A quantitative autoradiographic study. Neuroscience, 1993, 56, 711-716 (Pubitemid 23290583)
181. Angelatou, F.; Pagonopoulou, O.; Maraziotis, T.; Olivier, A.; Villemeure, J.G.; Avoli, M.; Kostopoulos, G. Upregulation of A1 adenosine receptors in human temporal lobe epilepsy: A quantitative autoradiographic study. Neurosci. Lett., 1993, 163, 11-14 (Pubitemid 23349383)
182. Glass, M.; Faull, R.L.; Bullock, J.Y.; Jansen, K.; Mee, E.W.; Walker, E.B.; Synek, B.J.; Dragunow, M. Loss of A1 adenosine receptors in human temporal lobe epilepsy. Brain Res., 1996, 710, 56-68 (Pubitemid 26083028)
183. Ekonomou, A.; Angelatou, F.; Vergnes, M.; Kostopoulos, G. Lower density of A1 adenosine receptors in nucleus reticularis thalami in rats with genetic absence epilepsy. Neuroreport, 1998, 9, 2135-2140 (Pubitemid 28300581)
184. Ochiishi, T.; Takita, M.; Ikemoto, M.; Nakata, H.; Suzuki, S.S. Immunohistochemical analysis on the role of adenosine A1 receptors in epilepsy. Neuroreport, 1999, 10, 3535-3541
185. Ekonomou, A.; Sperk, G.; Kostopoulos, G.; Angelatou, F. Reduction of A1 adenosine receptors in rat hippocampus after kainic acid-induced limbic seizures. Neurosci. Lett., 2000, 284, 49-52 (Pubitemid 30193196)
186. Rebola, N.; Coelho, J.E.; Costenla, A.R.; Lopes, L.V.; Parada, A.; Oliveira, C.R.; Soares-da-Silva, P.; de Mendonca, A.; Cunha, R.A. Decrease of adenosine A1 receptor density and of adenosine neuromodulation in the hippocampus of kindled rats. Eur. J. Neurosci., 2003, 18, 820-828 (Pubitemid 37059692)
187. Rebola, N.; Porciuncula, L.O.; Lopes, L.V.; Oliveira, C.R.; Soares-da-Silva, P.; Cunha, R.A. Long-term effect of convulsive behavior on the density of adenosine A1 and A 2A receptors in the rat cerebral cortex. Epilepsia, 2005, 46 Suppl 5, 159-165 (Pubitemid 40962140)
188. Aden, U.; O'Connor, W.T.; Berman, R.F. Changes in purine levels and adenosine receptors in kindled seizures in the rat. Neuroreport, 2004, 15, 1585-1589 (Pubitemid 38971176)
189. Simonato, M.; Varani, K.; Muzzolini, A.; Bianchi, C.; Beani, L.; Borea, P.A. Adenosine A1 receptors in the rat brain in the kindling model of epilepsy. Eur. J. Pharmacol., 1994, 265, 121-124 (Pubitemid 24356771)
190. Doriat, J.F.; Koziel, V.; Humbert, A.C.; Daval, J.L. Medium- and long-term alterations of brain A1 and A2A adenosine receptor characteristics following repeated seizures in developing rats. Epilepsy Res., 1999, 35, 219-228 (Pubitemid 29298115)
191. Kochanek, P.M.; Vagni, V.A.; Janesko, K.L.; Washington, C.B.; Crumrine, P.K.; Garman, R.H.; Jenkins, L.W.; Clark, R.S.; Homanics, G.E.; Dixon, C.E.; Schnermann, J.; Jackson, E.K. Adenosine A1 receptor knockout mice develop lethal status epilepticus after experimental traumatic brain injury. J. Cereb. Blood Flow Metab, 2006, 26, 565-575
192. Fedele, D.E.; Li, T.; Lan, J.Q.; Fredholm, B.B.; Boison, D. Adenosine A1 receptors are crucial in keeping an epileptic focus localized. Exp. Neurol., 2006, 200, 184-190 (Pubitemid 44080760)
193. Haselkorn, M.L.; Shellington, D.K.; Jackson, E.K.; Vagni, V.A.; Janesko- Feldman, K.; Dubey, R.K.; Gillespie, D.G.; Cheng, D.; Bell, M.J.; Jenkins, L.W.; Homanics, G.E.; Schnermann, J.; Kochanek, P.M. Adenosine A1 receptor activation as a brake on the microglial response after experimental traumatic brain injury in mice. J. Neurotrauma, 2010, 27, 901-910
194. Cronstein, B.N. Adenosine, an endogenous anti-inflammatory agent. J. Appl. Physiol, 1994, 76, 5-13
195. Gebicke-Haerter, P.J.; Christoffel, F.; Timmer, J.; Northoff, H.; Berger, M.; van Calker, D. Both adenosine A1- and A2-receptors are required to stimulate microglial proliferation. Neurochem. Int., 1996, 29, 37-42 (Pubitemid 26276502)
196. Hasko, G.; Pacher, P.; Vizi, E.S.; Illes, P. Adenosine receptor signaling in the brain immune system. Trends Pharmacol. Sci., 2005, 26, 511-516 (Pubitemid 41338561)
197. Ciccarelli, R.; Di Iorio, P.; Bruno, V.; Battaglia, G.; D'Alimonte, I.; D'Onofrio, M.; Nicoletti, F.; Caciagli, F. Activation of A(1) adenosine or mGlu3 metabotropic glutamate receptors enhances the release of nerve growth factor and S-100beta protein from cultured astrocytes. Glia, 1999, 27, 275-281 (Pubitemid 29413918)
198. Villoslada, P.; Genain, C.P. Role of nerve growth factor and other trophic factors in brain inflammation. Prog. Brain Res., 2004, 146, 403-414 (Pubitemid 37541396)
199. Schnurr, M.; Toy, T.; Shin, A.; Hartmann, G.; Rothenfusser, S.; Soellner, J.; Davis, I.D.; Cebon, J.; Maraskovsky, E. Role of adenosine receptors in regulating chemotaxis and cytokine production of plasmacytoid dendritic cells. Blood, 2004, 103, 1391-1397 (Pubitemid 38168654)
200. Tsutsui, S.; Schnermann, J.; Noorbakhsh, F.; Henry, S.; Yong, V.W.; Winston, B.W.; Warren, K.; Power, C. A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis. J. Neurosci., 2004, 24, 1521-1529 (Pubitemid 38223004)
201. Chen, G.Q.; Chen, Y.Y.; Wang, X.S.; Wu, S.Z.; Yang, H.M.; Xu, H.Q.; He, J.C.; Wang, X.T.; Chen, J.F.; Zheng, R.Y. Chronic caffeine treatment attenuates experimental autoimmune encephalomyelitis induced by guinea pig spinal cord homogenates in Wistar rats. Brain Res., 2010, 1309, 116-125
202. Brothers, H.M.; Marchalant, Y.; Wenk, G.L. Caffeine attenuates lipopolysaccharide-induced neuroinflammation. Neurosci. Lett., 2010, 480, 97-100
203. Jhaveri, K.A.; Reichensperger, J.; Toth, L.A.; Sekino, Y.; Ramkumar, V. Reduced basal and lipopolysaccharide-stimulated adenosine A1 receptor expression in the brain of nuclear factor-kappaB p50-/- mice. Neuroscience, 2007, 146, 415-426 (Pubitemid 46654598)
204. Synowitz, M.; Glass, R.; Farber, K.; Markovic, D.; Kronenberg, G.; Herrmann, K.; Schnermann, J.; Nolte, C.; Van Rooijen, N.; Kiwit, J.; Kettenmann, H. A1 adenosine receptors in microglia control glioblastomahost interaction. Cancer Res., 2006, 66, 8550-8557 (Pubitemid 44449168)
205. Bauer, A.; Langen, K.J.; Bidmon, H.; Holschbach, M.H.; Weber, S.; Olsson, R.A.; Coenen, H.H.; Zilles, K. 18F-CPFPX PET identifies changes in cerebral A1 adenosine receptor density caused by glioma invasion. J. Nucl. Med., 2005, 46, 450-454 (Pubitemid 43093154)
206. Jansen, K.L.; Faull, R.L.; Dragunow, M.; Synek, B.L. Alzheimer's disease: C hanges in hippocampal N-methyl-D-aspartate, quisqualate, neurotensin, adenosine, benzodiazepine, serotonin and opioid receptors-an autoradiographic study. Neuroscience, 1990, 39, 613-627
207. Kalaria, R.N.; Sromek, S.; Wilcox, B.J.; Unnerstall, J.R. Hippocampal adenosine A1 receptors are decreased in Alzheimer's disease. Neurosci. Lett., 1990, 118, 257-260
208. Jaarsma, D.; Sebens, J.B.; Korf, J. Reduction of adenosine A1-receptors in the perforant pathway terminal zone in Alzheimer hippocampus. Neurosci. Lett., 1991, 121, 111-114
209. Ulas, J.; Brunner, L.C.; Nguyen, L.; Cotman, C.W. Reduced density of adenosine A1 receptors and preserved coupling of adenosine A1 receptors to G proteins in Alzheimer hippocampus: A quantitative autoradiographic study. Neuroscience, 1993, 52, 843-854 (Pubitemid 23063529)
210. Ikeda, M.; Mackay, K.B.; Dewar, D.; McCulloch, J. Differential alterations in adenosine A1 and kappa 1 opioid receptors in the striatum in Alzheimer's disease. Brain Res., 1993, 616, 211-217 (Pubitemid 23200049)
211. Angulo, E.; Casado, V.; Mallol, J.; Canela, E.I.; Vinals, F.; Ferrer, I.; Lluis, C.; Franco, R. A1 adenosine receptors accumulate in neurodegenerative structures in Alzheimer disease and mediate both amyloid precursor protein processing and tau phosphorylation and translocation. Brain Pathol., 2003, 13, 440-451 (Pubitemid 37420689)
212. Albasanz, J.L.; Perez, S.; Barrachina, M.; Ferrer, I.; Martin, M. Upregulation of adenosine receptors in the frontal cortex in Alzheimer's disease. Brain Pathol., 2008, 18, 211-219 (Pubitemid 351430397)
213. Fukumitsu, N.; Ishii, K.; Kimura, Y.; Oda, K.; Hashimoto, M.; Suzuki, M.; Ishiwata, K. Adenosine A(1) receptors using 8-dicyclopropylmethyl-1- [(11)C]methyl-3-propylxanthine PET in Alzheimer's disease. Ann. Nucl. Med., 2008, 22, 841-847
214. Albasanz, J.L.; Rodriguez, A.; Ferrer, I.; Martin, M. Up-regulation of adenosine A1 receptors in frontal cortex from Pick's disease cases. Eur. J. Neurosci., 2007, 26, 3501-3508 (Pubitemid 350243536)
215. Rodriguez, A.; Martin, M.; Albasanz, J.L.; Barrachina, M.; Espinosa, J.C.; Torres, J.M.; Ferrer, I. Adenosine A1 Receptor Protein Levels and Activity Is Increased in the Cerebral Cortex in Creutzfeldt-Jakob Disease and in Bovine Spongiform Encephalopathy-Infected Bovine-PrP Mice. J. Neuropathol. Exp. Neurol., 2006, 65, 964-975 (Pubitemid 44521797)
216. Mayne, M.; Shepel, P.N.; Jiang, Y.; Geiger, J.D.; Power, C. Dysregulation of adenosine A1 receptor-mediated cytokine expression in peripheral blood mononuclear cells from multiple sclerosis patients. Ann. Neurol., 1999, 45, 633-639 (Pubitemid 29217592)
217. Johnston, J.B.; Silva, C.; Gonzalez, G.; Holden, J.; Warren, K.G.; Metz, L.M.; Power, C. Diminished adenosine A1 receptor expression on macrophages in brain and blood of patients with multiple sclerosis. Ann. Neurol., 2001, 49, 650-658 (Pubitemid 32429792)
218. Liu, H.Q.; Zhang, W.Y.; Luo, X.T.; Ye, Y.; Zhu, X.Z. Paeoniflorin attenuates neuroinflammation and dopaminergic neurodegeneration in the MPTP model of Parkinson's disease by activation of adenosine A1 receptor. Br. J. Pharmacol., 2006, 148, 314-325 (Pubitemid 43801179)
219. Bekar, L.; Libionka, W.; Tian, G.F.; Xu, Q.; Torres, A.; Wang, X.; Lovatt, D.; Williams, E.; Takano, T.; Schnermann, J.; Bakos, R.; Nedergaard, M. Adenosine is crucial for deep brain stimulation-mediated attenuation of tremor. Nat. Med., 2008, 14, 75-80
220. Lara, D.R.; Dall'Igna, O.P.; Ghisolfi, E.S.; Brunstein, M.G. Involvement of adenosine in the neurobiology of schizophrenia and its therapeutic implications. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2006, 30, 617-629
221. Boison, D.; Singer, P.; Shen, H.Y.; Feldon, J.; Yee, B.K. Adenosine hypothesis of schizophrenia - Opportunities for pharmacotherapy. Neuropharmacology, 2011, doi 10.1016/j.neuropharm.2011.01.048.
222. Gotoh, L.; Mitsuyasu, H.; Kobayashi, Y.; Oribe, N.; Takata, A.; Ninomiya, H.; Stanton, V.P., Jr.; Springett, G.M.; Kawasaki, H.; Kanba, S. Association analysis of adenosine A1 receptor gene (ADORA1) polymorphisms with schizophrenia in a Japanese population. Psychiatr. Genet., 2009, 19, 328-335
223. Meyer, P.T.; Bier, D.; Holschbach, M.H.; Cremer, M.; Tellmann, L.; Bauer, A. In vivo imaging of rat brain A1 adenosine receptor occupancy by caffeine. Eur. J. Nucl. Med. Mol. Imaging, 2003, 30, 1440 (Pubitemid 37247964)
224. Meyer, P.T.; Elmenhorst, D.; Matusch, A.; Winz, O.; Zilles, K.; Bauer, A. A1 adenosine receptor PET using [18F]CPFPX: D isplacement studies in humans. Neuroimage., 2006, 32, 1100-1105 (Pubitemid 44278674)
225. Arch, J.R.; Newsholme, E.A. The control of the metabolism and the hormonal role of adenosine. Essays Biochem., 1978, 14, 82-123
226. Newby, A.C.; Holmquist, C.A.; Illingworth, J.; Pearson, J.D. The control of adenosine concentration in polymorphonuclear leucocytes, cultured heart cells and isolated perfused heart from the rat. Biochem. J., 1983, 214, 317-323 (Pubitemid 13035512)
227. Engler, R. Consequences of activation and adenosine-mediated inhibition of granulocytes during myocardial ischemia. Fed. Proc., 1987, 46, 2407-2412 (Pubitemid 17081555)
228. Britton, D.R.; Mikusa, J.; Lee, C.H.; Jarvis, M.F.; Williams, M.; Kowaluk, E.A. Site and event specific increase of striatal adenosine release by adenosine kinase inhibition in rats. Neurosci. Lett., 1999, 266, 93-96 (Pubitemid 29227332)
229. Kowaluk, E.A.; Jarvis, M.F. Therapeutic potential of adenosine kinase inhibitors. Expert. Opin. Investig. Drugs, 2000, 9, 551-564 (Pubitemid 30119693)
230. Kowaluk, E.A.; Bhagwat, S.S.; Jarvis, M.F. Adenosine kinase inhibitors. Curr. Pharm. Des, 1998, 4, 403-416 (Pubitemid 28459502)
231. Sawynok, J.; Sweeney, M.I.; White, T.D. Classification of adenosine receptors mediating antinociception in the rat spinal cord. Br. J. Pharmacol., 1986, 88, 923-930 (Pubitemid 16013101)
232. Poon, A.; Sawynok, J. Antinociception by adenosine analogs and inhibitors of adenosine metabolism in an inflammatory thermal hyperalgesia model in the rat. Pain, 1998, 74, 235-245 (Pubitemid 28081610)
233. Poon, A.; Sawynok, J. Antinociception by adenosine analogs and an adenosine kinase inhibitor: D ependence on formalin concentration. Eur. J. Pharmacol., 1995, 286, 177-184
234. McGaraughty, S.; Chu, K.L.; Wismer, C.T.; Mikusa, J.; Zhu, C.Z.; Cowart, M.; Kowaluk, E.A.; Jarvis, M.F. Effects of A-134974, a novel adenosine kinase inhibitor, on carrageenan-induced inflammatory hyperalgesia and locomotor activity in rats: E valuation of the sites of action. J. Pharmacol. Exp. Ther., 2001, 296, 501-509 (Pubitemid 32112479)
235. Jarvis, M.F.; Yu, H.; Kohlhaas, K.; Alexander, K.; Lee, C.H.; Jiang, M.; Bhagwat, S.S.; Williams, M.; Kowaluk, E.A. ABT-702 (4-amino-5-(3- bromophenyl)-7-(6-morpholinopyridin-3-yl)pyrido[2, 3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and antiinflammatory properties: I. In vitro characterization and acute antinociceptive effects in the mouse. J. Pharmacol. Exp. Ther., 2000, 295, 1156-1164
236. Lee, Y.W.; Yaksh, T.L. Pharmacology of the spinal adenosine receptor which mediates the antiallodynic action of intrathecal adenosine agonists. J. Pharmacol. Exp. Ther., 1996, 277, 1642-1648 (Pubitemid 27167182)
237. Suzuki, R.; Stanfa, L.C.; Kowaluk, E.A.; Williams, M.; Jarvis, M.F.; Dickenson, A.H. The effect of ABT-702, a novel adenosine kinase inhibitor, on the responses of spinal neurones following carrageenan inflammation and peripheral nerve injury. Br. J. Pharmacol., 2001, 132, 1615-1623 (Pubitemid 32281052)
238. Kowaluk, E.A.; Mikusa, J.; Wismer, C.T.; Zhu, C.Z.; Schweitzer, E.; Lynch, J.J.; Lee, C.H.; Jiang, M.; Bhagwat, S.S.; Gomtsyan, A.; McKie, J.; Cox, B.F.; Polakowski, J.; Reinhart, G.; Williams, M.; Jarvis, M.F. ABT-702 (4- amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3- d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties. II. In vivo characterization in the rat. J. Pharmacol. Exp. Ther., 2000, 295, 1165-1174
239. Jarvis, M.F.; Yu, H.; McGaraughty, S.; Wismer, C.T.; Mikusa, J.; Zhu, C.; Chu, K.; Kohlhaas, K.; Cowart, M.; Lee, C.H.; Stewart, A.O.; Cox, B.F.; Polakowski, J.; Kowaluk, E.A. Analgesic and anti-inflammatory effects of A-286501, a novel orally active adenosine kinase inhibitor. Pain, 2002, 96, 107-118 (Pubitemid 34270633)
240. Kowaluk, E.A.; Kohlhaas, K.L.; Bannon, A.; Gunther, K.; Lynch, J.J., III; Jarvis, M.F. Characterization of the effects of adenosine kinase inhibitors on acute thermal nociception in mice. Pharmacol. Biochem. Behav., 1999, 63, 83-91 (Pubitemid 29206565)
241. Lynch, J.J., III; Jarvis, M.F.; Kowaluk, E.A. An adenosine kinase inhibitor attenuates tactile allodynia in a rat model of diabetic neuropathic pain. Eur. J. Pharmacol., 1999, 364, 141-146 (Pubitemid 29065263)
242. Jarvis, M.F.; Mikusa, J.; Chu, K.L.; Wismer, C.T.; Honore, P.; Kowaluk, E.A.; McGaraughty, S. Comparison of the ability of adenosine kinase inhibitors and adenosine receptor agonists to attenuate thermal hyperalgesia and reduce motor performance in rats. Pharmacol. Biochem. Behav., 2002, 73, 573-581 (Pubitemid 34876708)
243. Cottam, H.B.; Wasson, D.B.; Shih, H.C.; Raychaudhuri, A.; Di Pasquale, G.; Carson, D.A. New adenosine kinase inhibitors with oral antiinflammatory activity: Synthesis and biological evaluation. J. Med. Chem., 1993, 36, 3424-3430 (Pubitemid 23335707)
244. Firestein, G.S.; Boyle, D.; Bullough, D.A.; Gruber, H.E.; Sajjadi, F.G.; Montag, A.; Sambol, B.; Mullane, K.M. Protective effect of an adenosine kinase inhibitor in septic shock. J. Immunol., 1994, 152, 5853-5859 (Pubitemid 24174165)
245. Rosengren, S.; Bong, G.W.; Firestein, G.S. Anti-inflammatory effects of an adenosine kinase inhibitor. Decreased neutrophil accumulation and vascular leakage. J. Immunol., 1995, 154, 5444-5451
246. Firestein, G.S. Anti-inflammatory effects of adenosine kinase inhibitors in acute and chronic inflammation. Drug Dev. Res., 1996, 39, 371-376 (Pubitemid 27199347)
247. Poon, A.; Sawynok, J. Antinociceptive and anti-inflammatory properties of an adenosine kinase inhibitor and an adenosine deaminase inhibitor. Eur. J. Pharmacol., 1999, 384, 123-138 (Pubitemid 30006946)
248. Cronstein, B.N.; Naime, D.; Firestein, G. The antiinflammatory effects of an adenosine kinase inhibitor are mediated by adenosine. Arthritis Rheum., 1995, 38, 1040-1045
249. Zhang, G.; Franklin, P.H.; Murray, T.F. Manipulation of endogenous adenosine in the rat prepiriform cortex modulates seizure susceptibility. J. Pharmacol. Exp. Ther., 1993, 264, 1415-1424 (Pubitemid 23318640)
250. Ugarkar, B.G.; Castellino, A.J.; DaRe, J.M.; Kopcho, J.J.; Wiesner, J.B.; Schanzer, J.M.; Erion, M.D. Adenosine kinase inhibitors. 2. Synthesis, enzyme inhibition, and antiseizure activity of diaryltubercidin analogues. J. Med. Chem., 2000, 43, 2894-2905 (Pubitemid 30599647)
251. Ugarkar, B.G.; DaRe, J.M.; Kopcho, J.J.; Browne, C.E., III; Schanzer, J.M.; Wiesner, J.B.; Erion, M.D. Adenosine kinase inhibitors. 1. Synthesis, enzyme inhibition, and antiseizure activity of 5-iodotubercidin analogues. J. Med. Chem., 2000, 43, 2883-2893 (Pubitemid 30599646)
252. McGaraughty, S.; Cowart, M.; Jarvis, M.F.; Berman, R.F. Anticonvulsant and antinociceptive actions of novel adenosine kinase inhibitors. Curr. Top. Med. Chem., 2005, 5, 43-58 (Pubitemid 40202109)
253. Pagonopoulou, O.; Efthimiadou, A.; Asimakopoulos, B.; Nikolettos, N.K. Modulatory role of adenosine and its receptors in epilepsy: Possible therapeutic approaches. Neurosci. Res., 2006, 56, 14-20 (Pubitemid 44404049)
254. Ishiwata, K.; Furuta, R.; Shimada, J.; Ishii, S.; Endo, K.; Suzuki, F.; Senda, M. Synthesis and preliminary evaluation of [11C]KF15372, a selective adenosine A1 antagonist. Appl. Radiat. Isot., 1995, 46, 1009-1013
255. Furuta, R.; Ishiwata, K.; Kiyosawa, M.; Ishii, S.; Saito, N.; Shimada, J.; Endo, K.; Suzuki, F.; Senda, M. Carbon-11-labeled KF15372: A potential central nervous system adenosine A1 receptor ligand. J. Nucl. Med., 1996, 37, 1203-1207 (Pubitemid 26329534)
256. Wakabayashi, S.; Nariai, T.; Ishiwata, K.; Nagaoka, T.; Hirakawa, K.; Oda, K.; Sakiyama, Y.; Shumiya, S.; Toyama, H.; Suzuki, F.; Senda, M. A PET study of adenosine A1 receptor in anesthetized monkey brain. Nucl. Med. Biol., 2000, 27, 401-406 (Pubitemid 30628701)
257. Noguchi, J.; Ishiwata, K.; Furuta, R.; Simada, J.; Kiyosawa, M.; Ishii, S.; Endo, K.; Suzuki, F.; Senda, M. Evaluation of carbon-11 labeled KF15372 and its ethyl and methyl derivatives as a potential CNS adenosine A1 receptor ligand. Nucl. Med. Biol., 1997, 24, 53-59 (Pubitemid 27145597)
258. Ishiwata, K.; Nariai, T.; Kimura, Y.; Oda, K.; Kawamura, K.; Ishii, K.; Senda, M.; Wakabayashi, S.; Shimada, J. Preclinical studies on [11C]MPDX for mapping adenosine A1 receptors by positron emission tomography. Ann. Nucl. Med., 2002, 16, 377-382 (Pubitemid 35407625)
259. Kiyosawa, M.; Ishiwata, K.; Noguchi, J.; Endo, K.; Wang, W.F.; Suzuki, F.; Senda, M. Neuroreceptor bindings and synaptic activity in visual system of monocularly enucleated rat. Jpn. J. Ophthalmol., 2001, 45, 264-269 (Pubitemid 32458001)
260. Wang, W.F.; Ishiwata, K.; Kiyosawa, M.; Shimada, J.; Senda, M.; Mochizuki, M. Adenosine A1 and benzodiazepine receptors and glucose metabolism in the visual structures of rats monocularly deprived by enucleation or eyelid suture at a sensitive period. Jpn. J. Ophthalmol., 2003, 47, 182-190 (Pubitemid 36547829)
261. Qing, G.L.T.; Suzuki, Y.; Kiyosawa, M.; Ishiwata, K.; Mochizuki, M. Functional and neuroreceptor imaging of the brain in bicuculline-induced dystonic rats. Tohoku J. Exp. Med., 2009, 217, 313-320
262. Kawamura, K.; Ishiwata, K. Improved synthesis of [11C]SA4503,[11C]MPDX and [11C]TMSX by use of [11C]methyl triflate. Ann. Nucl. Med., 2004, 18, 165-168 (Pubitemid 38856013)
263. Shimada, Y.; Ishiwata, K.; Kiyosawa, M.; Nariai, T.; Oda, K.; Toyama, H.; Suzuki, F.; Ono, K.; Senda, M. Mapping adenosine A(1) receptors in the cat brain by positron emission tomography with [(11)C]MPDX. Nucl. Med. Biol., 2002, 29, 29-37 (Pubitemid 34088161)
264. Fukumitsu, N.; Ishii, K.; Kimura, Y.; Oda, K.; Sasaki, T.; Mori, Y.; Ishiwata, K. Imaging of adenosine A1 receptors in the human brain by positron emission tomography with [11C]MPDX. Ann. Nucl. Med., 2003, 17, 511-515 (Pubitemid 37221597)
265. Fukumitsu, N.; Ishii, K.; Kimura, Y.; Oda, K.; Sasaki, T.; Mori, Y.; Ishiwata, K. Adenosine A1 receptor mapping of the human brain by PET with 8- dicyclopropylmethyl-1-11C-methyl-3-propylxanthine. J. Nucl. Med., 2005, 46, 32-37 (Pubitemid 43085994)
266. Kimura, Y.; Ishii, K.; Fukumitsu, N.; Oda, K.; Sasaki, T.; Kawamura, K.; Ishiwata, K. Quantitative analysis of adenosine A1 receptors in human brain using positron emission tomography and [1-methyl-11C]8- dicyclopropylmethyl-1- methyl-3-propylxanthine. Nucl. Med. Biol., 2004, 31, 975-981 (Pubitemid 39647664)
267. Holschbach, M.H.; Olsson, R.A.; Bier, D.; Wutz, W.; Sihver, W.; Schuller, M.; Palm, B.; Coenen, H.H. Synthesis and evaluation of no-carrier-added 8- cyclopentyl-3-(3-[(18)F]fluoropropyl)-1-propylxanthine ([(18)F]CPFPX): A potent and selective A(1)-adenosine receptor antagonist for in vivo imaging. J. Med. Chem., 2002, 45, 5150-5156 (Pubitemid 35278710)
268. Bauer, A.; Holschbach, M.H.; Cremer, M.; Weber, S.; Boy, C.; Shah, N.J.; Olsson, R.A.; Halling, H.; Coenen, H.H.; Zilles, K. Evaluation of 18FCPFPX, a novel adenosine A1 receptor ligand: In vitro autoradiography and high-resolution small animal PET. J. Nucl. Med., 2003, 44, 1682-1689 (Pubitemid 39663344)
269. Bauer, A.; Holschbach, M.H.; Meyer, P.T.; Boy, C.; Herzog, H.; Olsson, R.A.; Coenen, H.H.; Zilles, K. In vivo imaging of adenosine A1 receptors in the human brain with [18F]CPFPX and positron emission tomography. Neuroimage., 2003, 19, 1760-1769 (Pubitemid 37025871)
270. Meyer, P.T.; Bier, D.; Holschbach, M.H.; Boy, C.; Olsson, R.A.; Coenen, H.H.; Zilles, K.; Bauer, A. Quantification of cerebral A1 adenosine receptors in humans using [18F]CPFPX and PET. J. Cereb. Blood Flow Metab, 2004, 24, 323-333 (Pubitemid 38314588)
271. Meyer, P.T.; Elmenhorst, D.; Bier, D.; Holschbach, M.H.; Matusch, A.; Coenen, H.H.; Zilles, K.; Bauer, A. Quantification of cerebral A1 adenosine receptors in humans using [18F]CPFPX and PET: A n equilibrium approach. Neuroimage., 2005, 24, 1192-1204 (Pubitemid 40164521)
272. Meyer, P.T.; Elmenhorst, D.; Zilles, K.; Bauer, A. Simplified quantification of cerebral A1 adenosine receptors using [18F]CPFPX and PET: A nalyses based on venous blood sampling. Synapse, 2005, 55, 212-223 (Pubitemid 40256303)
273. Meyer, P.T.; Elmenhorst, D.; Matusch, A.; Winz, O.; Zilles, K.; Bauer, A. 18F-CPFPX PET: On the generation of parametric images and the effect of scan duration. J. Nucl. Med., 2006, 47, 200-207 (Pubitemid 46780883)
274. Elmenhorst, D.; Meyer, P.T.; Matusch, A.; Winz, O.H.; Zilles, K.; Bauer, A. Test-retest stability of cerebral A1 adenosine receptor quantification using [18F]CPFPX and PET. Eur. J. Nucl. Med. Mol. Imaging, 2007, 34, 1061-1070 (Pubitemid 46919546)
275. Matusch, A.; Meyer, P.T.; Bier, D.; Holschbach, M.H.; Woitalla, D.; Elmenhorst, D.; Winz, O.H.; Zilles, K.; Bauer, A. Metabolism of the A1 adenosine receptor PET ligand [18F]CPFPX by CYP1A2: Implications for bolus/infusion PET studies. Nucl. Med. Biol., 2006, 33, 891-898 (Pubitemid 44512132)
276. Bier, D.; Holschbach, M.H.; Wutz, W.; Olsson, R.A.; Coenen, H.H. Metabolism of the A(1)1 adenosine receptor positron emission tomography ligand [18F]8-cyclopentyl-3-(3-fluoropropyl)-1-propylxanthine ([18F] CPFPX) in rodents and humans. Drug Metab Dispos., 2006, 34, 570-576
277. Sihver, W.; Holschbach, M.H.; Bier, D.; Wutz, W.; Schulze, A.; Olsson, R.A.; Coenen, H.H. Evaluation of radioiodinated 8-Cyclopentyl-3-[(E)-3- iodoprop-2-en-1-yl]-1-propylxanthine ([*I]CPIPX) as a new potential A1 adenosine receptor antagonist for SPECT. Nucl. Med. Biol., 2003, 30, 661-668 (Pubitemid 37289328)
278. Blum, T.; Elmert, J.; Wutz, W.; Bier, D.; Coenen, H.H. First no-carrier added radioselenation of an adenosine A1 receptor ligand. J. Label. Compd. Radiopharm., 2004, 47, 415-427 (Pubitemid 38915439)
279. Lehel, S.Z.; Horvath, G.; Boros, I.; Mikecz, P.; Marian, T.; Szentmiklosi, A.J.; Tron, L. Synthesis of 5'-N-(2-[18F]fluoroethyl)- carboxamidoadenosine: A promising tracer for investigation of adenosine receptor system by PET technique. J. Label. Compd. Radiopharm., 2000, 43, 807-815 (Pubitemid 30389100)